Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Toremifene × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Desmoid Tumors 1

Interventions

Radiotherapy 39 Temozolomide 31 Magnetic Resonance Spectroscopy 31 Doxorubicin 30 Cyclophosphamide 30 Specimen Handling 29 Vincristine 23 Etoposide 20 Radiation 19 Filgrastim 18 Biopsy 18 Ifosfamide 17 Bevacizumab 15 X-Rays 12 Sirolimus 12 Nivolumab 12 temsirolimus 11 Sorafenib 11 Ipilimumab 11 Imatinib Mesylate 11 Carboplatin 11 Surgical Procedures, Operative 10 Methotrexate 10 Irinotecan 10 Radiotherapy, Conformal 9 Peripheral Blood Stem Cell Transplantation 9 Immunoglobulin G 9 Disulfides 9 CTLA-4 Antigen 9 sargramostim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00002595 2013-07-10

Toremifene in Treating Patients With Desmoid Tumors

National Cancer Institute (NCI)

Phase 2 Completed

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡